MediWound Ltd. (MDWD) Stock

Healthcare · Biotechnology · Member of Other US Stocks

MediWound Ltd. (MDWD) closed at USD 11.91 on 2026-10-14, a change of -34.8 % over the past year, with a market capitalization of USD 157.63M.

MediWound Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

MediWound Ltd. key figures

Previous close

USD 11.91 (2026-10-14)

1-year change

-34.8 %

Market cap

USD 157.63M

Enterprise value

USD 130.9M

P/E ratio (trailing)

-5.63

P/E ratio (forward)

-5.33

EPS (trailing)

-2.17

EPS (forward)

-2.29

PEG ratio

n/a

Price to book

4.42

Revenue growth

-45.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

18.61

Employees

121

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About MediWound Ltd.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for MediWound Ltd. and compare it with other stocks.